This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Many of the claims made for the benefits of health tests marketed to U.K. consumers are unsubstantiated, with little information provided on their potential harms and limitations, finds an assessment of the websites of 50 commercial test vendors, published in the journal BMJ Open.
The sector is predicted to increase globally from $1.6 billion in 2023 to $3.2 billion by 2029, so there's an urgent need for stronger regulatory protection for consumers, insist the researchers.
Commercial tests can include blood tests, medical imaging, physical examination and physiological testing, sold individually or in "packages," explain the researchers.
But there is scant evidence of their effectiveness in healthy people, and concerns have been raised about their accuracy and the risk of false-positive/false-negative results, overdiagnosis, overtreatment and "mental and/or physical harm," they add.
The researchers therefore wanted to gauge the current availability of commercially available screening tests marketed to U.K. consumers and to find out whether current practice protects them and the NHS from the consequences of inappropriate testing.
They identified a sample of 50 U.K. individuals, companies and clinics—including major providers—promoting health tests to healthy people in the U.K. online.
, pelvic and breast examinations).
Source link







